CUIMC/Presbyterian Hospital and Vanderbilt Clinic
622 West 168th Street
Floor 14
New York, NY 10032
Have you seen this provider?
Get Directionsto 622 West 168th Street (opens in new tab)
Insurances Accepted
Before your appointment, please contact the doctor's office or your insurance provider to verify that your insurance is accepted. This list of insurances can change, and the insurance plans listed may not be accepted at all office locations for this provider.
- Student Health
- Aetna Signature Administrators
- Medicare Managed Care
- NY Signature
- POS
- EPO
- HMO
- PPO
- Medicaid Managed Care
- Essential Plan
- Special Needs
- Medicare Managed Care
- PPO
- HMO
- Great West (National)
- EPO
- POS
- PPO
- Medicare Managed Care
- Vytra
- Select Care (Exchange)
- Medicaid Managed Care
- Essential Plan
- ConnectiCare
- POS
- EPO
- PPO
- Medicare Managed Care
- HMO
- Child/Family Health Plus
- Essential Plan
- Medicaid Managed Care
- HMO
- PPO
- EPO
- Medicare Managed Care
- Essential Plan
- Child/Family Health Plus
- Medicare Managed Care
- Medicaid Managed Care
- Leaf (Exchange)
- Child/Family Health Plus
- Medicare Managed Care
- Medicaid Managed Care
- Medicare Managed Care
- Local 1199
- MagnaCare
- Traditional Medicare
- Railroad
- Multiplan
- Child/Family Health Plus
- Medicaid Managed Care
- Essential Plan
- HMO
- Special Needs
- Empire Plan
- Compass (Exchange)
- HMO
- PPO
- POS
- Oxford Liberty
- Oxford Freedom
- Oxford HMO
- Medicare Managed Care
- Medicaid (Community Plan)
- Special Needs
- Medicare Managed Care
- SelectHealth
- Medicaid Managed Care
- Medicare Managed Care
- World Trade Center Health Plan
About Julia J Wattacheril, MD, MPH
Julia Wattacheril, MD, MPH is an associate professor of medicine, physician scientist, inventor and director of the Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) program at Columbia University Irving Medical Center. Her clinical and translational work spans the multidisciplinary care of MASLD patients at all stages of their disease including the investigation of rare genetic variants influencing progression and regression of all chronic liver disease. Recent innovation awards in surgery and engineering highlight her tech development in machine learning to identify and stratify MASLD patients within electronic health records (EHRs) for prevention of disease progression inclusive of liver cancers.
Board Certifications
Languages Spoken
Specialties & Expertise
EDUCATION
- Medical School: Baylor College of Medicine
- Fellowship: Vanderbilt University Medical Center
- Residency: Baylor College of Medicine
- Fellowship: NewYork-Presbyterian Hospital/Columbia University Medical Center
LEADERSHIP, TITLES & POSITIONS
- Associate Professor of Medicine at CUMC
- Director of the Nonalcoholic Fatty Liver Disease Program
- Attending, New York - Presbyterian Hospital
HOSPITAL AFFILIATIONS
- NewYork-Presbyterian / Columbia University Irving Medical Center
- NewYork-Presbyterian / Weill Cornell Medical Center
AWARDS & HONORS
- 2024 Department of Surgery Innovation Award
- 2024 Department of Biomedical Engineering Ignite Award
- 2003 Alpha Omega Alpha
- 2000 Glasgow-Rubin Achievement Citation recipient, American Medical Womens Association
